Antigenic Peptides Derived From Telomerase

Abstract

This invention relates to proteins or peptides that elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognizing and destroying tumor cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.


Claims
Owners (US)

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Sep 14, 2010
  • Application: Jan 17, 2006
    US US 33237806 A
  • Priority: Jan 17, 2006
    US US 33237806 A
  • Priority: Jul 5, 2001
    US US 74328101 A
  • Priority: Jun 30, 1999
    NO NO 9900220 W
  • Priority: Jul 8, 1998
    NO NO 983141 A

Download Citation


Sign in to the Lens

Feedback